SIGA vs. FLXN, ORGO, ETNB, EBS, AMPH, GERN, VERA, AMRX, RCKT, and CPRX
Should you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include Flexion Therapeutics (FLXN), Organogenesis (ORGO), 89bio (ETNB), Emergent BioSolutions (EBS), Amphastar Pharmaceuticals (AMPH), Geron (GERN), Vera Therapeutics (VERA), Amneal Pharmaceuticals (AMRX), Rocket Pharmaceuticals (RCKT), and Catalyst Pharmaceuticals (CPRX). These companies are all part of the "medical" sector.
Flexion Therapeutics (NASDAQ:FLXN) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, community ranking, risk, analyst recommendations and media sentiment.
90.0% of Flexion Therapeutics shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 9.1% of Flexion Therapeutics shares are owned by insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, SIGA Technologies had 3 more articles in the media than Flexion Therapeutics. MarketBeat recorded 3 mentions for SIGA Technologies and 0 mentions for Flexion Therapeutics. Flexion Therapeutics' average media sentiment score of 0.94 beat SIGA Technologies' score of 0.00 indicating that SIGA Technologies is being referred to more favorably in the news media.
SIGA Technologies has a net margin of 50.48% compared to SIGA Technologies' net margin of -100.32%. Flexion Therapeutics' return on equity of 51.97% beat SIGA Technologies' return on equity.
SIGA Technologies has higher revenue and earnings than Flexion Therapeutics. Flexion Therapeutics is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks.
Flexion Therapeutics received 567 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 64.93% of users gave Flexion Therapeutics an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote.
Flexion Therapeutics has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.
Summary
SIGA Technologies beats Flexion Therapeutics on 9 of the 15 factors compared between the two stocks.
Get SIGA Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SIGA Technologies Competitors List
Related Companies and Tools
